Regional audit on fluoroquinolones usage in the hospital and the community: Are these antibiotics over-used?;Audit régional de l'usage des fluoroquinolones à l'hôpital et en ville: y a-t-il une surconsommation de ces antibiotiques ?

Pathologie Biologie

Volumn 59, Issue 5, 2011, Pages

  Leroy, J ^a   Patry, I ^a   Faure, C ^a   Ariskina, E ^a   Gaume, J P ^b   Henon T ^a   Ruyer, O ^c   Faller, J P ^c   Hoen, B ^a   Bertrand, X ^a   Talon, D ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c Centre Hospitalier de Belfort Montbeliard   (France)

Author keywords

Antibiotic prescription; Audit; Ecological impact; Fluoroquinolones; Urinary tract infection

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; DRUG USE; GENERAL PRACTITIONER; HEALTH CARE FACILITY; HOSPITAL PHYSICIAN; HOSPITAL SERVICE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL AUDIT; PRESCRIPTION; PROSPECTIVE STUDY; TREATMENT INDICATION; URINARY TRACT INFECTION;

ANTI-INFECTIVE AGENTS; CLINICAL AUDIT; FLUOROQUINOLONES; GENERAL PRACTICE; GUIDELINE ADHERENCE; HOSPITALS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTION DRUGS;

EID: 80053608160     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2009.09.002     Document Type: Article

References (23)

1. Bishai W. Current issues on resistance, treatment guidelines, and the appropriate use of fluoroquinolones for respiratory tract infections. Clin Ther 2002, 24:838-850.
2. Hooper D.C. Fluoroquinolone resistance among Gram-positive cocci. Lancet Infect Dis 2002, 2:530-538.
3. Zervos M.J., Hershberger E., Nicolau D.P., Ritchie D.J., Blackner L.K., Coyle E.A., et al. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin Infect Dis 2003, 37:1643-1648.
4. Trystram D., Grenet K., Cambau E., Pean Y., Fievet M.H., Jarlier V., et al. Évolution de la sensibilité aux quinolones et aux fluoroquinolones des bacilles à Gram négatif aérobies isolés dans un hôpital universitaire (1992-2000). Evolution of susceptibility to quinolones of aerobie Gram-bacilli isolated in an university hospital. Pathol Biol (Paris) 2002, 50:30-37.
5. Ena J., Lopez-Perezagua M.M., Martinez-Peinado C., Cia-Barrio M.A., Ruiz-Lopez I. Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquinolones. Diagn Microbiol Infect Dis 1998, 30:103-107.
6. Lautenbach E., Fishman N.O., Bilker W.B., Castiglioni A., Metlay J.P., Edelstein P.H., et al. Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Arch Intern Med 2002, 162:2469-2477.
7. Charbonneau P., Parienti J.J., Thibon P., Ramakers M., Daubin C., du Cheyron D., et al. Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study. Clin Infect Dis 2006, 42:778-784.
8. Muller A., Mauny F., Talon D., Donnan P.T., Harbarth S., Bertrand X. Effect of individual- and group-level antibiotic exposure on MRSA isolation: a multilevel analysis. J Antimicrob Chemother 2006, 58:878-881.
9. Bisognano C., Vaudaux P., Rohner P., Lew D.P., Hooper D.C. Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother 2000, 44:1428-1437.
10. Neuhauser M.M., Weinstein R.A., Rydman R., Danziger L.H., Karam G., Quinn J.P. Antibiotic resistance among Gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 2003, 289:885-888.
11. Bakken J.S. The fluoroquinolones: how long will their utility last?. Scand J Infect Dis 2004, 36:85-92.
12. Hooton T.M., Besser R., Foxman B., Fritsche T.R., Nicolle L.E. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis 2004, 39:75-80.
13. Sanchez F., Mensa J., Martinez J.A., Garcia E., Marco F., Gonzalez J., et al. Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia?. Clin Infect Dis 2003, 36:1239-1245.
14. Faure H, Mahy S, Soudry A, Duong M, Chavanet P, Piroth L. Déterminants de la prescription ou de la non-prescription d'antibiotiques en médecine générale. Med Mal Infect 2009:39:714-21.
15. Benoit S.R., Nsa W., Richards C.L., Bratzler D.W., Shefer A.M., Steele L.M., et al. Factors associated with antimicrobial use in nursing homes: a multilevel model. J Am Geriatr Soc 2008, 56:2039-2044.
16. McIsaac W.J., Prakash P., Ross S. The management of acute uncomplicated cystitis in adult women by family physicians in Canada. Can J Infect Dis Med Microbiol 2008, 19:287-293.
17. Huang E.S., Stafford R.S. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Arch Intern Med 2002, 162:41-47.
18. Carrie A.G., Metge C.J., Zhanel G.G. Antibiotic use in a Canadian Province, 1995-1998. Ann Pharmacother 2000, 34:459-464.
19. Patrick D.M., Marra F., Hutchinson J., Monnet D.L., Ng H., Bowie W.R. Per capita antibiotic consumption: how does a North American jurisdiction compare with Europe?. Clin Infect Dis 2004, 39:11-17.
20. Vogel T., Verreault R., Gourdeau M., Morin M., Grenier-Gosselin L., Rochette L. Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial. CMAJ 2004, 170:469-473.
21. Feron J.M., Legrand D., Pestiaux D., Tulkens P. Prescription d'antibiotiques en médecine générale en Belgique et en France: entre déterminants collectifs et responsabilité individuelle. Pathol Biol (Paris) 2009, 57:61-64.
22. Warren J.W., Abrutyn E., Hebel J.R., Johnson J.R., Schaeffer A.J., Stamm W.E. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999, 29:745-758.
23. Nicolle L., Anderson P.A., Conly J., Mainprize T.C., Meuser J., Nickel J.C., et al. Uncomplicated urinary tract infection in women. Current practice and the effect of antibiotic resistance on empiric treatment. Can Fam Physician 2006, 52:612-618.